Low CD4+ T-cell counts in HIV patients receiving effective antiretroviral therapy are associated with CD4+ T-cell activation and senescence but not with lower effector memory T-cell function

Sonia Fernandez, Patricia Price, E.J. Mckinnon, R.C. Nolan, Martyn French

    Research output: Contribution to journalArticle

    52 Citations (Scopus)

    Abstract

    The adverse effects of immune activation on CD4(+) T-cell recovery and the relationship between CD4(+) T-cell counts and effector T-cell function were examined in HIV-1 patients receiving tong-term effective ART. Patients with nadir CD4(+) T-cell counts < 100/mu l, > 12 months on ART and > 6 months with < 50 HIV RNA copies/ml were stratified by current CD4(+) T-cell counts and patients from the lowest (n = 15) and highest (n = 12) tertiles were studied. We assessed proliferation (Ki67), activation (HLA-DR, CD38) and replicative senescence (CD57) by flow cytometry and CD4(+) T-cell responses to CMV by IFN-gamma ELISpot. Proportions of CD4(+) T-cells expressing HLA-DR or CD57 were strong univariate predictors of total (P = 0.0002 and P = 0.002) and naive (P < 0.0001 and P < 0.0001, respectively) CD4(+) T-cell counts, suggesting that CD4(+) Tcell activation drives the depletion of naive CD4(+) T-cells. This was clearest in patients with a small/undetectable thymus. IFN-gamma responses to CMV were similar in patients with tow or high CD4(+) T-cell counts. (c) 2006 Elsevier Inc. All rights reserved.
    Original languageEnglish
    Pages (from-to)163-170
    JournalClinical Immunology
    Volume120
    Issue number2
    DOIs
    Publication statusPublished - 2006

    Fingerprint

    Dive into the research topics of 'Low CD4+ T-cell counts in HIV patients receiving effective antiretroviral therapy are associated with CD4+ T-cell activation and senescence but not with lower effector memory T-cell function'. Together they form a unique fingerprint.

    Cite this